MedPath

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Phase 3
Terminated
Conditions
Atrial Fibrillation
Interventions
Drug: Placebo (for warfarin)
Drug: Placebo (for idrabiotaparinux)
Drug: Placebo (for avidin)
Registration Number
NCT00580216
Lead Sponsor
Sanofi
Brief Summary

The objective is to evaluate whether once weekly subcutaneous (SC) injection of idrabiotaparinux sodium (biotinylated idraparinux) is at least as efficient to prevent clots in brain and in the other organs than oral international normalized ratio (INR) adjusted-dose warfarin in patients with atrial fibrillation (AF).

Detailed Description

The end of the study is defined by a common study end date for all participants, defined as 9 months (39 weeks) after the last participant randomized.

All participants will receive oral warfarin (or matching placebo) and weekly SC injections of idrabiotaparinux sodium (or matching placebo) up to 6 months before the common study end date. All participants are expected to be treated for at least 6 months.

All participants will have then an 6-month observational period after cessation of study treatment.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
3773
Inclusion Criteria
  • Non valvular atrial fibrillation (AF)
  • Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack (TIA) or systemic embolism and/or at least two of the following risk factors: hypertension requiring drug treatment, moderately or severely impaired left ventricular function and/or congestive heart failure, age > or = 75 years, diabetes mellitus.

Main exclusion Criteria:

  • Indication for VKA other than AF
  • Stroke or TIA within previous 5 days
  • Transient AF caused by a reversible disorder
  • Planned major surgery/trauma or cardioversion within 30 days
  • INR > 3 at baseline
  • Active bleeding or high risk of bleeding
  • Uncontrolled hypertension
  • Pregnancy or childbearing potential without proper contraceptive measures or breast feeding.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IdrabiotaparinuxPlacebo (for warfarin)Idrabiotaparinux sodium, 3.0 mg, once-weekly for 7 weeks followed a maintenance dosing adjusted according to the age and to the renal function for a minimum total treatment duration of 6 months. Avidin, 100 mg, at the discretion of the investigator whenever deemed appropriate and possible (ie, life-threatening bleeding, emergency invasive procedure with the potential of uncontrolled bleeding, or overdosage).
WarfarinPlacebo (for idrabiotaparinux)Warfarin, INR-adjusted dose, for a minimum total treatment duration of 6 months.
WarfarinPlacebo (for avidin)Warfarin, INR-adjusted dose, for a minimum total treatment duration of 6 months.
IdrabiotaparinuxIdrabiotaparinux sodiumIdrabiotaparinux sodium, 3.0 mg, once-weekly for 7 weeks followed a maintenance dosing adjusted according to the age and to the renal function for a minimum total treatment duration of 6 months. Avidin, 100 mg, at the discretion of the investigator whenever deemed appropriate and possible (ie, life-threatening bleeding, emergency invasive procedure with the potential of uncontrolled bleeding, or overdosage).
WarfarinWarfarinWarfarin, INR-adjusted dose, for a minimum total treatment duration of 6 months.
IdrabiotaparinuxAvidinIdrabiotaparinux sodium, 3.0 mg, once-weekly for 7 weeks followed a maintenance dosing adjusted according to the age and to the renal function for a minimum total treatment duration of 6 months. Avidin, 100 mg, at the discretion of the investigator whenever deemed appropriate and possible (ie, life-threatening bleeding, emergency invasive procedure with the potential of uncontrolled bleeding, or overdosage).
Primary Outcome Measures
NameTimeMethod
Composite of all fatal or non-fatal strokes or non central nervous system (CNS) systemic embolic events (SE)From randomization up to the end of the treatment period (minimum of 6 months)
Secondary Outcome Measures
NameTimeMethod
Components of the primary study outcome measure:From randomization up to the end of the treatment period (minimum of 6 months)
Composite of stroke or non CNS SE or myocardial infarction (MI) or venous thromboembolism (VTE) or major bleeding or deathFrom randomization up to the end of the treatment period (minimum of 6 months)

Trial Locations

Locations (538)

Sanofi-Aventis Investigational Site Number 840128

🇺🇸

Philadelphia, Pennsylvania, United States

Sanofi-Aventis Investigational Site Number 840181

🇺🇸

Pittsburgh, Pennsylvania, United States

Sanofi-Aventis Investigational Site Number 840146

🇺🇸

Cleveland, Ohio, United States

Sanofi-Aventis Investigational Site Number 840227

🇺🇸

Mobile, Alabama, United States

Sanofi-Aventis Investigational Site Number 840224

🇺🇸

Little Rock, Arkansas, United States

Sanofi-Aventis Investigational Site Number 840009

🇺🇸

Redondo Beach, California, United States

Sanofi-Aventis Investigational Site Number 840241

🇺🇸

Burbank, California, United States

Sanofi-Aventis Investigational Site Number 840220

🇺🇸

Fort Lauderdale, Florida, United States

Sanofi-Aventis Investigational Site Number 840209

🇺🇸

Tucson, Arizona, United States

Sanofi-Aventis Investigational Site Number 840270

🇺🇸

Beverly Hills, California, United States

Sanofi-Aventis Investigational Site Number 840255

🇺🇸

Little Rock, Arkansas, United States

Sanofi-Aventis Investigational Site Number 840265

🇺🇸

Lexington, Kentucky, United States

Sanofi-Aventis Investigational Site Number 840213

🇺🇸

Orange, California, United States

Sanofi-Aventis Investigational Site Number 840198

🇺🇸

Melbourne, Florida, United States

Sanofi-Aventis Investigational Site Number 840012

🇺🇸

St. Petersburg, Florida, United States

Sanofi-Aventis Investigational Site Number 840183

🇺🇸

Los Banos, California, United States

Sanofi-Aventis Investigational Site Number 840317

🇺🇸

Denton, Maryland, United States

Sanofi-Aventis Investigational Site Number 840218

🇺🇸

Jena, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840131

🇺🇸

Hollywood, Florida, United States

Sanofi-Aventis Investigational Site Number 840184

🇺🇸

Long Beach, California, United States

Sanofi-Aventis Investigational Site Number 840273

🇺🇸

Augusta, Georgia, United States

Sanofi-Aventis Investigational Site Number 840017

🇺🇸

Baltimore, Maryland, United States

Sanofi-Aventis Investigational Site Number 840290

🇺🇸

Columbus, Georgia, United States

Sanofi-Aventis Investigational Site Number 840298

🇺🇸

Riverside, California, United States

Sanofi-Aventis Investigational Site Number 840003

🇺🇸

Niceville, Florida, United States

Sanofi-Aventis Investigational Site Number 840084

🇺🇸

Dunnellon, Florida, United States

Sanofi-Aventis Investigational Site Number 840268

🇺🇸

Bridgeport, Connecticut, United States

Sanofi-Aventis Investigational Site Number 840066

🇺🇸

Beach, Florida, United States

Sanofi-Aventis Investigational Site Number 840143

🇺🇸

Nampa, Idaho, United States

Sanofi-Aventis Investigational Site Number 840310

🇺🇸

St. Louis, Missouri, United States

Sanofi-Aventis Investigational Site Number 840232

🇺🇸

Shreveport, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840033

🇺🇸

Loma Linda, California, United States

Sanofi-Aventis Investigational Site Number 840195

🇺🇸

Encino, California, United States

Sanofi-Aventis Investigational Site Number 840272

🇺🇸

Northridge, California, United States

Sanofi-Aventis Investigational Site Number 840145

🇺🇸

Auburn, Maine, United States

Sanofi-Aventis Investigational Site Number 840138

🇺🇸

Ft. Lauderdale, Florida, United States

Sanofi-Aventis Investigational Site Number 840276

🇺🇸

Brighton, Michigan, United States

Sanofi-Aventis Investigational Site Number 840280

🇺🇸

Beaver, Indiana, United States

Sanofi-Aventis Investigational Site Number 840247

🇺🇸

Lafayette, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840311

🇺🇸

Alpena, Michigan, United States

Sanofi-Aventis Investigational Site Number 840006

🇺🇸

Picayune, Mississippi, United States

Sanofi-Aventis Investigational Site Number 840127

🇺🇸

Hickory, North Carolina, United States

Sanofi-Aventis Investigational Site Number 840229

🇺🇸

Scotland, Pennsylvania, United States

Sanofi-Aventis Investigational Site Number 840165

🇺🇸

Savannah, Georgia, United States

Sanofi-Aventis Investigational Site Number 840026

🇺🇸

Mason, Ohio, United States

Sanofi-Aventis Investigational Site Number 840064

🇺🇸

Wadsworth, Ohio, United States

Sanofi-Aventis Investigational Site Number 840228

🇺🇸

Idaho Falls, Idaho, United States

Sanofi-Aventis Investigational Site Number 840152

🇺🇸

Johnson City, New York, United States

Sanofi-Aventis Investigational Site Number 840221

🇺🇸

Chicago, Illinois, United States

Sanofi-Aventis Investigational Site Number 840323

🇺🇸

St. Louis, Missouri, United States

Sanofi-Aventis Investigational Site Number 840110

🇺🇸

Palm Harbor, Florida, United States

Sanofi-Aventis Investigational Site Number 840130

🇺🇸

Idaho Falls, Idaho, United States

Sanofi-Aventis Investigational Site Number 840047

🇺🇸

Alexandria, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840109

🇺🇸

Linden, New Jersey, United States

Sanofi-Aventis Investigational Site Number 840113

🇺🇸

Bend, Oregon, United States

Sanofi-Aventis Investigational Site Number 840137

🇺🇸

St. Clair Shores, Michigan, United States

Sanofi-Aventis Investigational Site Number 840189

🇺🇸

Pelzer, South Carolina, United States

Sanofi-Aventis Investigational Site Number 840201

🇺🇸

St Louis, Missouri, United States

Sanofi-Aventis Investigational Site Number 840284

🇺🇸

Bronx, New York, United States

Sanofi-Aventis Investigational Site Number 840197

🇺🇸

Centerville, Ohio, United States

Sanofi-Aventis Investigational Site Number 840159

🇺🇸

Rochester, New York, United States

Sanofi-Aventis Investigational Site Number 840085

🇺🇸

Newberry, South Carolina, United States

Sanofi-Aventis Investigational Site Number 840233

🇺🇸

Toledo, Ohio, United States

Sanofi-Aventis Investigational Site Number 036006

🇦🇺

Adelaide, Australia

Sanofi-Aventis Investigational Site Number 840150

🇺🇸

Raleigh, North Carolina, United States

Sanofi-Aventis Investigational Site Number 840160

🇺🇸

Philadelphia, Pennsylvania, United States

Sanofi-Aventis Investigational Site Number 076019

🇧🇷

Belo Horizonte, Brazil

Sanofi-Aventis Investigational Site Number 840024

🇺🇸

Morristown, New Jersey, United States

Sanofi-Aventis Investigational Site Number 840056

🇺🇸

Westfield, New York, United States

Sanofi-Aventis Investigational Site Number 840005

🇺🇸

Odessa, Texas, United States

Sanofi-Aventis Investigational Site Number 840058

🇺🇸

Everett, Washington, United States

Sanofi-Aventis Investigational Site Number 840219

🇺🇸

Springfield, Virginia, United States

Sanofi-Aventis Investigational Site Number 032007

🇦🇷

Buenos Aires, Argentina

Sanofi-Aventis Investigational Site Number 840072

🇺🇸

Stoneboro, Pennsylvania, United States

Sanofi-Aventis Investigational Site Number 840339

🇺🇸

Philadelphia, Pennsylvania, United States

Sanofi-Aventis Investigational Site Number 840261

🇺🇸

Anderson, South Carolina, United States

Sanofi-Aventis Investigational Site Number 076012

🇧🇷

Porto Alegre, Brazil

Sanofi-Aventis Investigational Site Number 840236

🇺🇸

Temple, Texas, United States

Sanofi-Aventis Investigational Site Number 036001

🇦🇺

Kippa Ring, Australia

Sanofi-Aventis Investigational Site Number 032001

🇦🇷

Buenos Aires, Argentina

Sanofi-Aventis Investigational Site Number 840122

🇺🇸

Manning, South Carolina, United States

Sanofi-Aventis Investigational Site Number 036002

🇦🇺

Kippa Ring, Australia

Sanofi-Aventis Investigational Site Number 032009

🇦🇷

Capital Federal, Argentina

Sanofi-Aventis Investigational Site Number 840076

🇺🇸

Amarillo, Texas, United States

Sanofi-Aventis Investigational Site Number 840285

🇺🇸

Wichita Falls, Texas, United States

Sanofi-Aventis Investigational Site Number 076007

🇧🇷

Campinas, Brazil

Sanofi-Aventis Investigational Site Number 036003

🇦🇺

Auchenflower, Australia

Sanofi-Aventis Investigational Site Number 124012

🇨🇦

Quebec, Canada

Sanofi-Aventis Investigational Site Number 840052

🇺🇸

Bristol, Tennessee, United States

Sanofi-Aventis Investigational Site Number 840011

🇺🇸

Victoria, Texas, United States

Sanofi-Aventis Investigational Site Number 032011

🇦🇷

Buenos Aires, Argentina

Sanofi-Aventis Investigational Site Number 076009

🇧🇷

Recife, Brazil

Sanofi-Aventis Investigational Site Number 076008

🇧🇷

Porto Alegre, Brazil

Sanofi-Aventis Investigational Site Number 036010

🇦🇺

Woden, Australia

Sanofi-Aventis Investigational Site Number 036009

🇦🇺

Launceston, Australia

Sanofi-Aventis Investigational Site Number 191001

🇭🇷

Zagreb, Croatia

Sanofi-Aventis Investigational Site Number 076001

🇧🇷

Curitiba, Brazil

Sanofi-Aventis Investigational Site Number 032006

🇦🇷

Mar Del Plata, Argentina

Sanofi-Aventis Investigational Site Number 032010

🇦🇷

Zarate, Argentina

Sanofi-Aventis Investigational Site Number 036008

🇦🇺

Box Hill, Australia

Sanofi-Aventis Investigational Site Number 124006

🇨🇦

Newmarket, Canada

Sanofi-Aventis Investigational Site Number 250018

🇫🇷

Dijon Cedex, France

Sanofi-Aventis Investigational Site Number 250022

🇫🇷

Cholet Cedex, France

Sanofi-Aventis Investigational Site Number 124014

🇨🇦

London, Canada

Sanofi-Aventis Investigational Site Number 076010

🇧🇷

Sao Paulo, Brazil

Sanofi-Aventis Investigational Site Number 076015

🇧🇷

Uberlandia, Brazil

Sanofi-Aventis Investigational Site Number 250032

🇫🇷

Montpellier, France

Sanofi-Aventis Investigational Site Number 376001

🇮🇱

Givatayim, Israel

Sanofi-Aventis Investigational Site Number 380015

🇮🇹

Ascoli Piceno, Italy

Sanofi-Aventis Investigational Site Number 191004

🇭🇷

Zagreb, Croatia

Sanofi-Aventis Investigational Site Number 250028

🇫🇷

Abbeville, France

Sanofi-Aventis Investigational Site Number 380010

🇮🇹

Merate, Italy

Sanofi-Aventis Investigational Site Number 380020

🇮🇹

Novara, Italy

Sanofi-Aventis Investigational Site Number 250030

🇫🇷

Metz Tessy, France

Sanofi-Aventis Investigational Site Number 250034

🇫🇷

Allauch, France

Sanofi-Aventis Investigational Site Number 376011

🇮🇱

Rehovot, Israel

Sanofi-Aventis Investigational Site Number 360002

🇮🇩

Jakarta, Indonesia

Sanofi-Aventis Investigational Site Number 410007

🇰🇷

Gwangju, Korea, Republic of

Sanofi-Aventis Investigational Site Number 376015

🇮🇱

Ashkelon, Israel

Sanofi-Aventis Investigational Site Number 250012

🇫🇷

Albi Cedex 9, France

Sanofi-Aventis Investigational Site Number 376007

🇮🇱

Haifa, Israel

Sanofi-Aventis Investigational Site Number 250004

🇫🇷

La Rochelle, France

Sanofi-Aventis Investigational Site Number 250011

🇫🇷

Bordeaux, France

Sanofi-Aventis Investigational Site Number 250029

🇫🇷

Le Chesnay Cedex, France

Sanofi-Aventis Investigational Site Number 250031

🇫🇷

Belfort Cedex, France

Sanofi-Aventis Investigational Site Number 250003

🇫🇷

Montpellier, France

Sanofi-Aventis Investigational Site Number 250008

🇫🇷

Paris Cedex 14, France

Sanofi-Aventis Investigational Site Number 528009

🇳🇱

Delft, Netherlands

Sanofi-Aventis Investigational Site Number 410001

🇰🇷

Seoul, Korea, Republic of

Sanofi-Aventis Investigational Site Number 380014

🇮🇹

Milano, Italy

Sanofi-Aventis Investigational Site Number 410012

🇰🇷

Goyang, Korea, Republic of

Sanofi-Aventis Investigational Site Number 380016

🇮🇹

Chieti, Italy

Sanofi-Aventis Investigational Site Number 376002

🇮🇱

Tel Aviv, Israel

Sanofi-Aventis Investigational Site Number 410005

🇰🇷

Seoul, Korea, Republic of

Sanofi-Aventis Investigational Site Number 380013

🇮🇹

San Daniele Del Friuli, Italy

Sanofi-Aventis Investigational Site Number 380003

🇮🇹

Sassari, Italy

Sanofi-Aventis Investigational Site Number 410011

🇰🇷

Seoul, Korea, Republic of

Sanofi-Aventis Investigational Site Number 380001

🇮🇹

Padova, Italy

Sanofi-Aventis Investigational Site Number 380004

🇮🇹

Palermo, Italy

Sanofi-Aventis Investigational Site Number 410008

🇰🇷

Anyang, Korea, Republic of

Sanofi-Aventis Investigational Site Number 410006

🇰🇷

Goyang, Korea, Republic of

Sanofi-Aventis Investigational Site Number 752003

🇸🇪

Göteborg, Sweden

Sanofi-Aventis Investigational Site Number 410004

🇰🇷

Seoul, Korea, Republic of

Sanofi-Aventis Investigational Site Number 554001

🇳🇿

Nelson, New Zealand

Sanofi-Aventis Investigational Site Number 528001

🇳🇱

Heerlen, Netherlands

Sanofi-Aventis Investigational Site Number 643036

🇷🇺

Chelyabinsk, Russian Federation

Sanofi-Aventis Investigational Site Number 554003

🇳🇿

Christchurch, New Zealand

Sanofi-Aventis Investigational Site Number 643040

🇷🇺

Chelyabinsk, Russian Federation

Sanofi-Aventis Investigational Site Number 643042

🇷🇺

Kemerovo, Russian Federation

Sanofi-Aventis Investigational Site Number 724005

🇪🇸

Santiago De Compostela, Spain

Sanofi-Aventis Investigational Site Number 643020

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643004

🇷🇺

Saratov, Russian Federation

Sanofi-Aventis Investigational Site Number 724007

🇪🇸

Sevilla, Spain

Sanofi-Aventis Investigational Site Number 710002

🇿🇦

Pretoria, South Africa

Sanofi-Aventis Investigational Site Number 643007

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643015

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643009

🇷🇺

Kemerovo, Russian Federation

Sanofi-Aventis Investigational Site Number 643038

🇷🇺

St-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643018

🇷🇺

St-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 752002

🇸🇪

Malmö, Sweden

Sanofi-Aventis Investigational Site Number 804015

🇺🇦

Dnepropetrovsk, Ukraine

Sanofi-Aventis Investigational Site Number 804012

🇺🇦

Kharkov, Ukraine

Sanofi-Aventis Investigational Site Number 643032

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 804003

🇺🇦

Kiev, Ukraine

Sanofi-Aventis Investigational Site Number 643050

🇷🇺

Chelyabinsk, Russian Federation

Sanofi-Aventis Investigational Site Number 710001

🇿🇦

Durban, South Africa

Sanofi-Aventis Investigational Site Number 710013

🇿🇦

Amanzimtoti, South Africa

Sanofi-Aventis Investigational Site Number 752006

🇸🇪

Göteborg, Sweden

Sanofi-Aventis Investigational Site Number 752007

🇸🇪

Malmo, Sweden

Sanofi-Aventis Investigational Site Number 752001

🇸🇪

Stockolm, Sweden

Sanofi-Aventis Investigational Site Number 643034

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 724003

🇪🇸

Barcelona, Spain

Sanofi-Aventis Investigational Site Number 643002

🇷🇺

St-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643022

🇷🇺

St-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 710018

🇿🇦

Umhlanga Rocks, South Africa

Sanofi-Aventis Investigational Site Number 643051

🇷🇺

Novosibirsk, Russian Federation

Sanofi-Aventis Investigational Site Number 792005

🇹🇷

Edirne, Turkey

Sanofi-Aventis Investigational Site Number 792002

🇹🇷

Istanbul, Turkey

Sanofi-Aventis Investigational Site Number 643003

🇷🇺

Saratov, Russian Federation

Sanofi-Aventis Investigational Site Number 643010

🇷🇺

St-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643021

🇷🇺

Tyumen, Russian Federation

Sanofi-Aventis Investigational Site Number 724002

🇪🇸

Barcelona, Spain

Sanofi-Aventis Investigational Site Number 804007

🇺🇦

Lutsk, Ukraine

Sanofi-Aventis Investigational Site Number 804009

🇺🇦

Lutsk, Ukraine

Sanofi-Aventis Investigational Site Number 710015

🇿🇦

Randburg, South Africa

Sanofi-Aventis Investigational Site Number 804011

🇺🇦

Odessa, Ukraine

Sanofi-Aventis Investigational Site Number 752004

🇸🇪

Ostersund, Sweden

Sanofi-Aventis Investigational Site Number 724001

🇪🇸

Madrid, Spain

Sanofi-Aventis Investigational Site Number 710014

🇿🇦

Scottburgh, South Africa

Sanofi-Aventis Investigational Site Number 158002

🇨🇳

Taichung, Taiwan

Sanofi-Aventis Investigational Site Number 804013

🇺🇦

Dnepropetrovsk, Ukraine

Sanofi-Aventis Investigational Site Number 804005

🇺🇦

Dnipropetrovsk, Ukraine

Sanofi-Aventis Investigational Site Number 804002

🇺🇦

Kharkov, Ukraine

Sanofi-Aventis Investigational Site Number 862001

🇻🇪

Caracas, Venezuela

Sanofi-Aventis Investigational Site Number 804010

🇺🇦

Ternopil, Ukraine

Sanofi-Aventis Investigational Site Number 840286

🇺🇸

Houston, Texas, United States

Sanofi-Aventis Investigational Site Number 840123

🇺🇸

Seattle, Washington, United States

Sanofi-Aventis Investigational Site Number 840051

🇺🇸

Las Vegas, Nevada, United States

Sanofi-Aventis Investigational Site Number 840117

🇺🇸

Miami, Florida, United States

Sanofi-Aventis Investigational Site Number 840264

🇺🇸

San Diego, California, United States

Sanofi-Aventis Investigational Site Number 840275

🇺🇸

San Diego, California, United States

Sanofi-Aventis Investigational Site Number 528026

🇳🇱

Breda, Netherlands

Sanofi-Aventis Investigational Site Number 528035

🇳🇱

Den Haag, Netherlands

Sanofi-Aventis Investigational Site Number 528027

🇳🇱

Ede, Netherlands

Sanofi-Aventis Investigational Site Number 528006

🇳🇱

Eindhoven, Netherlands

Sanofi-Aventis Investigational Site Number 528017

🇳🇱

Eindhoven, Netherlands

Sanofi-Aventis Investigational Site Number 528016

🇳🇱

Gouda, Netherlands

Sanofi-Aventis Investigational Site Number 528007

🇳🇱

Harderwijk, Netherlands

Sanofi-Aventis Investigational Site Number 528024

🇳🇱

Heerlen, Netherlands

Sanofi-Aventis Investigational Site Number 528003

🇳🇱

Hengelo, Netherlands

Sanofi-Aventis Investigational Site Number 528010

🇳🇱

Hengelo, Netherlands

Sanofi-Aventis Investigational Site Number 528019

🇳🇱

Hoorn, Netherlands

Sanofi-Aventis Investigational Site Number 528021

🇳🇱

Venlo, Netherlands

Sanofi-Aventis Investigational Site Number 528013

🇳🇱

Rotterdam, Netherlands

Sanofi-Aventis Investigational Site Number 528002

🇳🇱

Sneek, Netherlands

Sanofi-Aventis Investigational Site Number 528033

🇳🇱

Tilburg, Netherlands

Sanofi-Aventis Investigational Site Number 528005

🇳🇱

Zoetermeer, Netherlands

Sanofi-Aventis Investigational Site Number 528025

🇳🇱

Zwolle, Netherlands

Sanofi-Aventis Investigational Site Number 840074

🇺🇸

Cincinnati, Ohio, United States

Sanofi-Aventis Investigational Site Number 840249

🇺🇸

Wichita, Kansas, United States

Sanofi-Aventis Investigational Site Number 208002

🇩🇰

Glostrup, Denmark

Sanofi-Aventis Investigational Site Number 208001

🇩🇰

Hellerup, Denmark

Sanofi-Aventis Investigational Site Number 208007

🇩🇰

Hvidovre, Denmark

Sanofi-Aventis Investigational Site Number 208003

🇩🇰

København S, Denmark

Sanofi-Aventis Investigational Site Number 208004

🇩🇰

Odense, Denmark

Sanofi-Aventis Investigational Site Number 208006

🇩🇰

Roskilde, Denmark

Sanofi-Aventis Investigational Site Number 380008

🇮🇹

Pavia, Italy

Sanofi-Aventis Investigational Site Number 380021

🇮🇹

Perugia, Italy

Sanofi-Aventis Investigational Site Number 380011

🇮🇹

Torino, Italy

Sanofi-Aventis Investigational Site Number 380009

🇮🇹

Treviso, Italy

Sanofi-Aventis Investigational Site Number 076017

🇧🇷

Goiania, Brazil

Sanofi-Aventis Investigational Site Number 076014

🇧🇷

Porto Alegre, Brazil

Sanofi-Aventis Investigational Site Number 076018

🇧🇷

Maceio, Brazil

Sanofi-Aventis Investigational Site Number 076005

🇧🇷

Sao Jose Do Rio Preto, Brazil

Sanofi-Aventis Investigational Site Number 250019

🇫🇷

Lille, France

Sanofi-Aventis Investigational Site Number 250015

🇫🇷

Lille, France

Sanofi-Aventis Investigational Site Number 250035

🇫🇷

Bron, France

Sanofi-Aventis Investigational Site Number 250006

🇫🇷

Dijon, France

Sanofi-Aventis Investigational Site Number 250014

🇫🇷

Paris Cedex 13, France

Sanofi-Aventis Investigational Site Number 250001

🇫🇷

Paris, France

Sanofi-Aventis Investigational Site Number 250002

🇫🇷

Vandoeuvre Les Nancy Cedex, France

Sanofi-Aventis Investigational Site Number 250026

🇫🇷

Toulouse Cedex 9, France

Sanofi-Aventis Investigational Site Number 112002

🇧🇾

Minsk, Belarus

Sanofi-Aventis Investigational Site Number 112001

🇧🇾

Minsk, Belarus

Sanofi-Aventis Investigational Site Number 100004

🇧🇬

Pleven, Bulgaria

Sanofi-Aventis Investigational Site Number 112003

🇧🇾

Minsk, Belarus

Sanofi-Aventis Investigational Site Number 040001

🇦🇹

Graz, Austria

Sanofi-Aventis Investigational Site Number 100002

🇧🇬

Sofia, Bulgaria

Sanofi-Aventis Investigational Site Number 112005

🇧🇾

Minsk, Belarus

Sanofi-Aventis Investigational Site Number 100005

🇧🇬

Plovdiv, Bulgaria

Sanofi-Aventis Investigational Site Number 203010

🇨🇿

Praha 6, Czech Republic

Sanofi-Aventis Investigational Site Number 246001

🇫🇮

Helsinki, Finland

Sanofi-Aventis Investigational Site Number 356005

🇮🇳

Chennai, India

Sanofi-Aventis Investigational Site Number 356017

🇮🇳

Mumbai, India

Sanofi-Aventis Investigational Site Number 100001

🇧🇬

Sofia, Bulgaria

Sanofi-Aventis Investigational Site Number 170005

🇨🇴

Envigado-Antioquia, Colombia

Sanofi-Aventis Investigational Site Number 203005

🇨🇿

Chomutov, Czech Republic

Sanofi-Aventis Investigational Site Number 203009

🇨🇿

Ostrava Vitkovice, Czech Republic

Sanofi-Aventis Investigational Site Number 152001

🇨🇱

Santiago, Chile

Sanofi-Aventis Investigational Site Number 152006

🇨🇱

Viña Del Mar, Chile

Sanofi-Aventis Investigational Site Number 170003

🇨🇴

Bogota, Colombia

Sanofi-Aventis Investigational Site Number 170006

🇨🇴

Bogota, Colombia

Sanofi-Aventis Investigational Site Number 152007

🇨🇱

Santiago, Chile

Sanofi-Aventis Investigational Site Number 203004

🇨🇿

Praha 4, Czech Republic

Sanofi-Aventis Investigational Site Number 818004

🇪🇬

Alexandria, Egypt

Sanofi-Aventis Investigational Site Number 300006

🇬🇷

Chalkida, Greece

Sanofi-Aventis Investigational Site Number 203001

🇨🇿

Pardubice, Czech Republic

Sanofi-Aventis Investigational Site Number 203011

🇨🇿

Plzen - Bory, Czech Republic

Sanofi-Aventis Investigational Site Number 203006

🇨🇿

Prostejov, Czech Republic

Sanofi-Aventis Investigational Site Number 818003

🇪🇬

Alexandria, Egypt

Sanofi-Aventis Investigational Site Number 818002

🇪🇬

Alexandria, Egypt

Sanofi-Aventis Investigational Site Number 233004

🇪🇪

Tallinn, Estonia

Sanofi-Aventis Investigational Site Number 233002

🇪🇪

Tartu, Estonia

Sanofi-Aventis Investigational Site Number 300004

🇬🇷

Chios, Greece

Sanofi-Aventis Investigational Site Number 818001

🇪🇬

Cairo, Egypt

Sanofi-Aventis Investigational Site Number 233001

🇪🇪

Tallinn, Estonia

Sanofi-Aventis Investigational Site Number 233003

🇪🇪

Tallinn, Estonia

Sanofi-Aventis Investigational Site Number 320002

🇬🇹

Guatemala, Guatemala

Sanofi-Aventis Investigational Site Number 300009

🇬🇷

Athens, Greece

Sanofi-Aventis Investigational Site Number 300007

🇬🇷

Athens, Greece

Sanofi-Aventis Investigational Site Number 300002

🇬🇷

Athens, Greece

Sanofi-Aventis Investigational Site Number 300005

🇬🇷

Athens, Greece

Sanofi-Aventis Investigational Site Number 356014

🇮🇳

Mysore, India

Sanofi-Aventis Investigational Site Number 484008

🇲🇽

Acapulco, Mexico

Sanofi-Aventis Investigational Site Number 484004

🇲🇽

Guadalajara, Mexico

Sanofi-Aventis Investigational Site Number 300008

🇬🇷

Elefsina, Greece

Sanofi-Aventis Investigational Site Number 320001

🇬🇹

Guatemala, Guatemala

Sanofi-Aventis Investigational Site Number 356006

🇮🇳

Lucknow, India

Sanofi-Aventis Investigational Site Number 320003

🇬🇹

Guatemala, Guatemala

Sanofi-Aventis Investigational Site Number 356010

🇮🇳

Ahmedabad, India

Sanofi-Aventis Investigational Site Number 356015

🇮🇳

Bangalore, India

Sanofi-Aventis Investigational Site Number 356009

🇮🇳

Bangalore, India

Sanofi-Aventis Investigational Site Number 356002

🇮🇳

Coimbatore, India

Sanofi-Aventis Investigational Site Number 356012

🇮🇳

New Delhi, India

Sanofi-Aventis Investigational Site Number 356011

🇮🇳

Pune, India

Sanofi-Aventis Investigational Site Number 356020

🇮🇳

Nashik, India

Sanofi-Aventis Investigational Site Number 440002

🇱🇹

Kaunas, Lithuania

Sanofi-Aventis Investigational Site Number 484012

🇲🇽

Mexico Df, Mexico

Sanofi-Aventis Investigational Site Number 504001

🇲🇦

Marrakech, Morocco

Sanofi-Aventis Investigational Site Number 578005

🇳🇴

Lørenskog, Norway

Sanofi-Aventis Investigational Site Number 591002

🇵🇦

Panama, Panama

Sanofi-Aventis Investigational Site Number 604004

🇵🇪

Lima, Peru

Sanofi-Aventis Investigational Site Number 616013

🇵🇱

Chojnice, Poland

Sanofi-Aventis Investigational Site Number 616012

🇵🇱

Ostrowiec Swietokrzyski, Poland

Sanofi-Aventis Investigational Site Number 484013

🇲🇽

Aguascalientes, Mexico

Sanofi-Aventis Investigational Site Number 440004

🇱🇹

Kaunas, Lithuania

Sanofi-Aventis Investigational Site Number 440003

🇱🇹

Vilnius, Lithuania

Sanofi-Aventis Investigational Site Number 458001

🇲🇾

Kuching, Malaysia

Sanofi-Aventis Investigational Site Number 458002

🇲🇾

Penang, Malaysia

Sanofi-Aventis Investigational Site Number 484016

🇲🇽

Aguascalientes, Mexico

Sanofi-Aventis Investigational Site Number 484010

🇲🇽

Monterrey, Mexico

Sanofi-Aventis Investigational Site Number 578006

🇳🇴

Flekkefjord, Norway

Sanofi-Aventis Investigational Site Number 591001

🇵🇦

Panama, Panama

Sanofi-Aventis Investigational Site Number 591003

🇵🇦

Panama, Panama

Sanofi-Aventis Investigational Site Number 616006

🇵🇱

Tychy, Poland

Sanofi-Aventis Investigational Site Number 616008

🇵🇱

Wroclaw, Poland

Sanofi-Aventis Investigational Site Number 484005

🇲🇽

San Luis Potosi, Mexico

Sanofi-Aventis Investigational Site Number 484011

🇲🇽

San Luis Potosi, Mexico

Sanofi-Aventis Investigational Site Number 484003

🇲🇽

Veracruz, Mexico

Sanofi-Aventis Investigational Site Number 504002

🇲🇦

Meknes, Morocco

Sanofi-Aventis Investigational Site Number 604002

🇵🇪

Lima, Peru

Sanofi-Aventis Investigational Site Number 604001

🇵🇪

Lima, Peru

Sanofi-Aventis Investigational Site Number 616015

🇵🇱

Pulawy, Poland

Sanofi-Aventis Investigational Site Number 578004

🇳🇴

Oslo, Norway

Sanofi-Aventis Investigational Site Number 578001

🇳🇴

Bergen, Norway

Sanofi-Aventis Investigational Site Number 604003

🇵🇪

Lima, Peru

Sanofi-Aventis Investigational Site Number 616014

🇵🇱

Gdynia-Redlowo, Poland

Sanofi-Aventis Investigational Site Number 608001

🇵🇭

Quezon City, Philippines

Sanofi-Aventis Investigational Site Number 616011

🇵🇱

Gdansk, Poland

Sanofi-Aventis Investigational Site Number 616017

🇵🇱

Lodz, Poland

Sanofi-Aventis Investigational Site Number 616007

🇵🇱

Torun, Poland

Sanofi-Aventis Investigational Site Number 616001

🇵🇱

Warszawa, Poland

Sanofi-Aventis Investigational Site Number 620002

🇵🇹

Amadora, Portugal

Sanofi-Aventis Investigational Site Number 620008

🇵🇹

Setubal, Portugal

Sanofi-Aventis Investigational Site Number 703005

🇸🇰

Levice, Slovakia

Sanofi-Aventis Investigational Site Number 158005

🇨🇳

Taipei, Taiwan

Sanofi-Aventis Investigational Site Number 703003

🇸🇰

Kosice, Slovakia

Sanofi-Aventis Investigational Site Number 862002

🇻🇪

Maracay, Venezuela

Sanofi-Aventis Investigational Site Number 158004

🇨🇳

Tainan Hsien, Taiwan

Sanofi-Aventis Investigational Site Number 158003

🇨🇳

Kaohsiung, Taiwan

Sanofi-Aventis Investigational Site Number 764002

🇹🇭

Bangkok-Noi, Thailand

Sanofi-Aventis Investigational Site Number 643016

🇷🇺

St-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643027

🇷🇺

St-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643005

🇷🇺

Saratov, Russian Federation

Sanofi-Aventis Investigational Site Number 643043

🇷🇺

Voronezh, Russian Federation

Sanofi-Aventis Investigational Site Number 840257

🇺🇸

Portland, Oregon, United States

Sanofi-Aventis Investigational Site Number 840186

🇺🇸

San Antonio, Texas, United States

Sanofi-Aventis Investigational Site Number 840269

🇺🇸

Nashville, Tennessee, United States

Sanofi-Aventis Investigational Site Number 840194

🇺🇸

San Antonio, Texas, United States

Sanofi-Aventis Investigational Site Number 840238

🇺🇸

Salt Lake City, Utah, United States

Sanofi-Aventis Investigational Site Number 840308

🇺🇸

Salt Lake City, Utah, United States

Sanofi-Aventis Investigational Site Number 032012

🇦🇷

Corrientes, Argentina

Sanofi-Aventis Investigational Site Number 032014

🇦🇷

Moron, Argentina

Sanofi-Aventis Investigational Site Number 840234

🇺🇸

Key West, Florida, United States

Sanofi-Aventis Investigational Site Number 840230

🇺🇸

Ocala, Florida, United States

Sanofi-Aventis Investigational Site Number 840116

🇺🇸

Sanford, Florida, United States

Sanofi-Aventis Investigational Site Number 840211

🇺🇸

Plantation, Florida, United States

Sanofi-Aventis Investigational Site Number 840243

🇺🇸

Spring Hill, Florida, United States

Sanofi-Aventis Investigational Site Number 840206

🇺🇸

Chicago, Illinois, United States

Sanofi-Aventis Investigational Site Number 643019

🇷🇺

Yaroslavl, Russian Federation

Sanofi-Aventis Investigational Site Number 840179

🇺🇸

Mountain Home, Arkansas, United States

Sanofi-Aventis Investigational Site Number 840118

🇺🇸

Visalia, California, United States

Sanofi-Aventis Investigational Site Number 840103

🇺🇸

Santa Ana, California, United States

Sanofi-Aventis Investigational Site Number 840111

🇺🇸

Torrance, California, United States

Sanofi-Aventis Investigational Site Number 840215

🇺🇸

Gainesville, Florida, United States

Sanofi-Aventis Investigational Site Number 840161

🇺🇸

Hollywood, Florida, United States

Sanofi-Aventis Investigational Site Number 840112

🇺🇸

Lake Mary, Florida, United States

Sanofi-Aventis Investigational Site Number 840022

🇺🇸

Ormond Beach, Florida, United States

Sanofi-Aventis Investigational Site Number 840082

🇺🇸

St. Petersburg, Florida, United States

Sanofi-Aventis Investigational Site Number 840073

🇺🇸

Atlanta, Georgia, United States

Sanofi-Aventis Investigational Site Number 840204

🇺🇸

Columbus, Georgia, United States

Sanofi-Aventis Investigational Site Number 840225

🇺🇸

Columbus, Georgia, United States

Sanofi-Aventis Investigational Site Number 840305

🇺🇸

Dunwoody, Georgia, United States

Sanofi-Aventis Investigational Site Number 840158

🇺🇸

Lake Charles, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840077

🇺🇸

Natchitoches, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840259

🇺🇸

Shreveport, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840242

🇺🇸

Detroit, Michigan, United States

Sanofi-Aventis Investigational Site Number 840231

🇺🇸

Shreveport, Louisiana, United States

Sanofi-Aventis Investigational Site Number 840134

🇺🇸

St Cloud, Minnesota, United States

Sanofi-Aventis Investigational Site Number 840253

🇺🇸

Grand Rapids, Michigan, United States

Sanofi-Aventis Investigational Site Number 840067

🇺🇸

Gulfport, Mississippi, United States

Sanofi-Aventis Investigational Site Number 840008

🇺🇸

Butte, Montana, United States

Sanofi-Aventis Investigational Site Number 840258

🇺🇸

Las Vegas, Nevada, United States

Sanofi-Aventis Investigational Site Number 840126

🇺🇸

Fremont, Nebraska, United States

Sanofi-Aventis Investigational Site Number 840303

🇺🇸

Hamilton, New Jersey, United States

Sanofi-Aventis Investigational Site Number 840102

🇺🇸

Buffalo, New York, United States

Sanofi-Aventis Investigational Site Number 840277

🇺🇸

Greensboro, North Carolina, United States

Sanofi-Aventis Investigational Site Number 840185

🇺🇸

Rocky Mount, North Carolina, United States

Sanofi-Aventis Investigational Site Number 840020

🇺🇸

Fargo, North Dakota, United States

Sanofi-Aventis Investigational Site Number 840292

🇺🇸

Gallipolis, Ohio, United States

Sanofi-Aventis Investigational Site Number 840045

🇺🇸

Oklahoma City, Oklahoma, United States

Sanofi-Aventis Investigational Site Number 840133

🇺🇸

Tulsa, Oklahoma, United States

Sanofi-Aventis Investigational Site Number 840297

🇺🇸

Anderson, South Carolina, United States

Sanofi-Aventis Investigational Site Number 840172

🇺🇸

Camden, South Carolina, United States

Sanofi-Aventis Investigational Site Number 840062

🇺🇸

Athens, Tennessee, United States

Sanofi-Aventis Investigational Site Number 840048

🇺🇸

Bristol, Tennessee, United States

Sanofi-Aventis Investigational Site Number 840248

🇺🇸

Cranston, Rhode Island, United States

Sanofi-Aventis Investigational Site Number 840032

🇺🇸

Fort Meade, South Dakota, United States

Sanofi-Aventis Investigational Site Number 840104

🇺🇸

Cleveland, Tennessee, United States

Sanofi-Aventis Investigational Site Number 840129

🇺🇸

Johnson City, Tennessee, United States

Sanofi-Aventis Investigational Site Number 840252

🇺🇸

Corsicana, Texas, United States

Sanofi-Aventis Investigational Site Number 840132

🇺🇸

Irving, Texas, United States

Sanofi-Aventis Investigational Site Number 840293

🇺🇸

Madison, Wisconsin, United States

Sanofi-Aventis Investigational Site Number 840256

🇺🇸

Beloit, Wisconsin, United States

Sanofi-Aventis Investigational Site Number 032005

🇦🇷

Buenos Aires, Argentina

Sanofi-Aventis Investigational Site Number 036005

🇦🇺

Coffs Harbour, Australia

Sanofi-Aventis Investigational Site Number 032016

🇦🇷

Salta, Argentina

Sanofi-Aventis Investigational Site Number 191003

🇭🇷

Split, Croatia

Sanofi-Aventis Investigational Site Number 040004

🇦🇹

Linz, Austria

Sanofi-Aventis Investigational Site Number 076011

🇧🇷

Campina Grande Do Sul, Brazil

Sanofi-Aventis Investigational Site Number 076013

🇧🇷

Campinas, Brazil

Sanofi-Aventis Investigational Site Number 076016

🇧🇷

Goiania, Brazil

Sanofi-Aventis Investigational Site Number 100003

🇧🇬

Sofia, Bulgaria

Sanofi-Aventis Investigational Site Number 124011

🇨🇦

Toronto, Canada

Sanofi-Aventis Investigational Site Number 152003

🇨🇱

Santiago, Chile

Sanofi-Aventis Investigational Site Number 152009

🇨🇱

Viña Del Mar, Chile

Sanofi-Aventis Investigational Site Number 152004

🇨🇱

Santiago, Chile

Sanofi-Aventis Investigational Site Number 152005

🇨🇱

Santiago, Chile

Sanofi-Aventis Investigational Site Number 152008

🇨🇱

Santiago, Chile

Sanofi-Aventis Investigational Site Number 170002

🇨🇴

Medellin, Colombia

Sanofi-Aventis Investigational Site Number 188004

🇨🇷

San José, Costa Rica

Sanofi-Aventis Investigational Site Number 170001

🇨🇴

Bucaramanga, Colombia

Sanofi-Aventis Investigational Site Number 203003

🇨🇿

Jihlava, Czech Republic

Sanofi-Aventis Investigational Site Number 203002

🇨🇿

Praha 2, Czech Republic

Sanofi-Aventis Investigational Site Number 203008

🇨🇿

Usti Nad Orlici, Czech Republic

Sanofi-Aventis Investigational Site Number 208005

🇩🇰

Svendborg, Denmark

Sanofi-Aventis Investigational Site Number 250010

🇫🇷

Brest Cedex 2, France

Sanofi-Aventis Investigational Site Number 250021

🇫🇷

Brest, France

Sanofi-Aventis Investigational Site Number 250016

🇫🇷

Nice Cedex, France

Sanofi-Aventis Investigational Site Number 250005

🇫🇷

Saint Etienne Cedex 2, France

Sanofi-Aventis Investigational Site Number 250027

🇫🇷

Tours Cedex 1, France

Sanofi-Aventis Investigational Site Number 356001

🇮🇳

Ahmedabad, India

Sanofi-Aventis Investigational Site Number 320004

🇬🇹

Guatemala, Guatemala

Sanofi-Aventis Investigational Site Number 356013

🇮🇳

Lucknow, India

Sanofi-Aventis Investigational Site Number 356007

🇮🇳

Coimbatore, India

Sanofi-Aventis Investigational Site Number 356004

🇮🇳

New Delhi, India

Sanofi-Aventis Investigational Site Number 356018

🇮🇳

Pune., India

Sanofi-Aventis Investigational Site Number 356003

🇮🇳

Secunderabad, India

Sanofi-Aventis Investigational Site Number 360001

🇮🇩

Jakarta, Indonesia

Sanofi-Aventis Investigational Site Number 376003

🇮🇱

Afula, Israel

Sanofi-Aventis Investigational Site Number 376004

🇮🇱

Holon, Israel

Sanofi-Aventis Investigational Site Number 376014

🇮🇱

Haifa, Israel

Sanofi-Aventis Investigational Site Number 376012

🇮🇱

Nahariya, Israel

Sanofi-Aventis Investigational Site Number 376009

🇮🇱

Nazareth, Israel

Sanofi-Aventis Investigational Site Number 380018

🇮🇹

Borgo San Lorenzo, Italy

Sanofi-Aventis Investigational Site Number 380005

🇮🇹

Fidenza, Italy

Sanofi-Aventis Investigational Site Number 380007

🇮🇹

Padova, Italy

Sanofi-Aventis Investigational Site Number 410002

🇰🇷

Daegu, Korea, Republic of

Sanofi-Aventis Investigational Site Number 410003

🇰🇷

Seongnam, Korea, Republic of

Sanofi-Aventis Investigational Site Number 440001

🇱🇹

Vilnius, Lithuania

Sanofi-Aventis Investigational Site Number 528030

🇳🇱

Amsterdam, Netherlands

Sanofi-Aventis Investigational Site Number 458005

🇲🇾

Taiping, Malaysia

Sanofi-Aventis Investigational Site Number 528012

🇳🇱

Almelo, Netherlands

Sanofi-Aventis Investigational Site Number 484007

🇲🇽

Guadalajara, Mexico

Sanofi-Aventis Investigational Site Number 528020

🇳🇱

Leeuwarden, Netherlands

Sanofi-Aventis Investigational Site Number 528031

🇳🇱

Hoogeveen, Netherlands

Sanofi-Aventis Investigational Site Number 528004

🇳🇱

Nijmegen, Netherlands

Sanofi-Aventis Investigational Site Number 528022

🇳🇱

Sittard-Geleen, Netherlands

Sanofi-Aventis Investigational Site Number 554002

🇳🇿

Dunedin, New Zealand

Sanofi-Aventis Investigational Site Number 604005

🇵🇪

Lima, Peru

Sanofi-Aventis Investigational Site Number 616009

🇵🇱

Katowice, Poland

Sanofi-Aventis Investigational Site Number 616002

🇵🇱

Lublin, Poland

Sanofi-Aventis Investigational Site Number 616010

🇵🇱

Warszawa, Poland

Sanofi-Aventis Investigational Site Number 620006

🇵🇹

Coimbra, Portugal

Sanofi-Aventis Investigational Site Number 620007

🇵🇹

Braga, Portugal

Sanofi-Aventis Investigational Site Number 643033

🇷🇺

Barnaul, Russian Federation

Sanofi-Aventis Investigational Site Number 630001

🇵🇷

San Juan, Puerto Rico

Sanofi-Aventis Investigational Site Number 643031

🇷🇺

Ekaterinburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643052

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643001

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643053

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643056

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643025

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643028

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643037

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643026

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643049

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643013

🇷🇺

Nizhny Novgorod, Russian Federation

Sanofi-Aventis Investigational Site Number 643039

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643011

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643030

🇷🇺

Moscow, Russian Federation

Sanofi-Aventis Investigational Site Number 643048

🇷🇺

Novosibirsk-117, Russian Federation

Sanofi-Aventis Investigational Site Number 643041

🇷🇺

Nizniy Novgorod, Russian Federation

Sanofi-Aventis Investigational Site Number 643023

🇷🇺

Perm, Russian Federation

Sanofi-Aventis Investigational Site Number 643044

🇷🇺

Novosibirsk, Russian Federation

Sanofi-Aventis Investigational Site Number 643045

🇷🇺

Penza, Russian Federation

Sanofi-Aventis Investigational Site Number 643006

🇷🇺

Perm, Russian Federation

Sanofi-Aventis Investigational Site Number 643012

🇷🇺

Rostov-Na-Donu, Russian Federation

Sanofi-Aventis Investigational Site Number 643047

🇷🇺

Saint-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643046

🇷🇺

Petrozavodsk, Russian Federation

Sanofi-Aventis Investigational Site Number 643008

🇷🇺

Ryazan, Russian Federation

Sanofi-Aventis Investigational Site Number 643017

🇷🇺

Saint-Petersburg, Russian Federation

Sanofi-Aventis Investigational Site Number 643029

🇷🇺

Samara, Russian Federation

Sanofi-Aventis Investigational Site Number 643035

🇷🇺

Tomsk, Russian Federation

Sanofi-Aventis Investigational Site Number 643024

🇷🇺

Tomsk, Russian Federation

Sanofi-Aventis Investigational Site Number 703004

🇸🇰

Nitra, Slovakia

Sanofi-Aventis Investigational Site Number 703006

🇸🇰

Poprad, Slovakia

Sanofi-Aventis Investigational Site Number 703002

🇸🇰

Trnava, Slovakia

Sanofi-Aventis Investigational Site Number 710007

🇿🇦

Cape Town, South Africa

Sanofi-Aventis Investigational Site Number 710011

🇿🇦

Bloemfontein, South Africa

Sanofi-Aventis Investigational Site Number 710017

🇿🇦

Cape Town, South Africa

Sanofi-Aventis Investigational Site Number 710009

🇿🇦

Johannesburg, South Africa

Sanofi-Aventis Investigational Site Number 710012

🇿🇦

Durban, South Africa

Sanofi-Aventis Investigational Site Number 710020

🇿🇦

Pretoria, South Africa

Sanofi-Aventis Investigational Site Number 710016

🇿🇦

Port Elizabeth, South Africa

Sanofi-Aventis Investigational Site Number 710003

🇿🇦

Pretoria, South Africa

Sanofi-Aventis Investigational Site Number 158001

🇨🇳

Taipei, Taiwan

Sanofi-Aventis Investigational Site Number 764001

🇹🇭

Bangkok, Thailand

Sanofi-Aventis Investigational Site Number 764003

🇹🇭

Muang, Thailand

Sanofi-Aventis Investigational Site Number 792004

🇹🇷

Edirne, Turkey

Sanofi-Aventis Investigational Site Number 792001

🇹🇷

Istanbul, Turkey

Sanofi-Aventis Investigational Site Number 792007

🇹🇷

Kocaeli, Turkey

Sanofi-Aventis Investigational Site Number 792003

🇹🇷

Istanbul, Turkey

Sanofi-Aventis Investigational Site Number 792006

🇹🇷

Kocaeli, Turkey

Sanofi-Aventis Investigational Site Number 804004

🇺🇦

Kharkiv, Ukraine

Sanofi-Aventis Investigational Site Number 804008

🇺🇦

Ivano-Frankivsk, Ukraine

Sanofi-Aventis Investigational Site Number 804006

🇺🇦

Uzhgorod, Ukraine

Sanofi-Aventis Investigational Site Number 840196

🇺🇸

Greensboro, North Carolina, United States

Sanofi-Aventis Investigational Site Number 840014

🇺🇸

Elkhart, Indiana, United States

Sanofi-Aventis Investigational Site Number 840168

🇺🇸

Columbia, South Carolina, United States

Sanofi-Aventis Investigational Site Number 840200

🇺🇸

St. Louis, Missouri, United States

Sanofi-Aventis Investigational Site Number 804014

🇺🇦

Zaporizhzhia, Ukraine

Sanofi-Aventis Investigational Site Number 840202

🇺🇸

Orlando, Florida, United States

Sanofi-Aventis Investigational Site Number 840306

🇺🇸

Orlando, Florida, United States

Sanofi-Aventis Investigational Site Number 840246

🇺🇸

Bay Pines, Florida, United States

Sanofi-Aventis Investigational Site Number 840304

🇺🇸

Indiana, Pennsylvania, United States

Sanofi-Aventis Investigational Site Number 840002

🇺🇸

Santa Rosa, California, United States

Sanofi-Aventis Investigational Site Number 840010

🇺🇸

Corona, California, United States

Sanofi-Aventis Investigational Site Number 840313

🇺🇸

Brandon, Florida, United States

Sanofi-Aventis Investigational Site Number 840289

🇺🇸

Odessa, Texas, United States

Sanofi-Aventis Investigational Site Number 840282

🇺🇸

Wauwatosa, Wisconsin, United States

Sanofi-Aventis Investigational Site Number 840053

🇺🇸

Lakeland, Florida, United States

Sanofi-Aventis Investigational Site Number 840278

🇺🇸

Beverly Hills, California, United States

Sanofi-Aventis Investigational Site Number 840096

🇺🇸

Anaconda, Montana, United States

Sanofi-Aventis Investigational Site Number 840223

🇺🇸

Clinton, Utah, United States

Sanofi-Aventis Investigational Site Number 840068

🇺🇸

Salem, Virginia, United States

Sanofi-Aventis Investigational Site Number 840019

🇺🇸

Tacoma, Washington, United States

Sanofi-Aventis Investigational Site Number 643054

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath